Medscape is the official provider of online conference coverage and continuing medical education activities based on the Second IAS Conference on HIV Pathogenesis and Treatment.
Contents
Although second-line and salvage therapy have improved significantly over the years, the selection and administration of initial antiretroviral therapy are essential to a patient's best chance of achieving and maintaining an undetectable viral load. Summarized here are several important new studies relevant to the selection of first-line agents and regimens, and to new approaches to first-line therapy, that were presented at the Second International AIDS Society Conference on HIV Pathogenesis and Treatment.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the International AIDS Society. These materials and the related activity are not sanctioned by the International AIDS Society or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.